The present invention relates to the derivatives of the formula ##STR1## where the substituents are defined in the specification. These compounds possess thromboxane receptor antagonist properties.
本发明涉及公式为##STR1##的衍
生物,其中取代基在规范中定义。这些化合物具有血栓素受体拮抗剂的性质。